All Data Analysis articles
-
ArticleManaging nitrosamine toxicological risk in late-stage development
When a nitrosamine drug substance-related impurity (NDSRI) is newly identified or increases above established control levels, opportunities for chemistry, manufacturing and control (CMC) mitigation may be limited. Toxicological assessment and impurity mitigation must therefore proceed in parallel. Alex Gauthier at Novartis reviews practical toxicological strategies for managing late-stage NDSRIs while maintaining patient safety and development timelines.
-
ArticleTesto at CPHI 2026 in Milan: digital monitoring for the pharmaceutical industry
At CPHI 2026, Testo will showcase digital solutions for monitoring, compliance, and supply chain transparency in the pharmaceutical industry.
-
NewsMSD-Moderna Phase III readout backs personalised mRNA neoantigen combination adjuvant therapy for melanoma
First combination regimen to demonstrate significant reduction in recurrence risk in completely resected stage IIB-IV melanoma compared to Keytruda alone as adjuvant treatment.
-
ArticleLab 4.0 balance: connected, compliant and ready to integrate
Combining connectivity, compliance and automation, Lab 4.0 connectivity simplifies workflows, reduces manual intervention and supports secure digital transformation in modern pharmaceutical laboratories.
-
NewsAbCellera’s ABCL635 delivers positive Phase II data for vasomotor symptoms
In early Phase II data, investigational antibody ABCL635 achieved all primary efficacy endpoints in postmenopausal women experiencing vasomotor symptoms.
-
WebinarModernising pharma QA/QC laboratories: preparing for a more connected, compliant future
Watch this webinar to discover how modern QA/QC laboratories are embracing digital transformation to enhance compliance, workflows and data integrity to build a more connected, future-ready pharmaceutical quality ecosystem.
-
WebinarEnsuring drug quality: mastering stability testing in pharma
Watch this webinar to discover how UV-Vis spectroscopy and gas chromatography support API monitoring, testing and analysis.
-
ReportPharma Horizons: Nitrosamines
EPR’s 2026 nitrosamines report covers the key developments in manufacturing, quality, regulation, analytical development and beyond.
-
ReportPharma Horizons: Process Analytical Technology (PAT)
The definitive guide to transitioning from manual, offline batch testing to automated, continuous biomanufacturing.
-
ArticleSelecting the right qPCR workflow strategy: task-based vs. full automation
Selecting the right qPCR workflow strategy: task-based vs. full automation
-
ReportPharma Horizons: Cell and Gene Therapy
EPR’s 2026 cell and gene therapy report covers the key developments in manufacturing, regulation, drug delivery, process development and beyond.
-
NewsBoehringer’s GLP-1 dual agonist survodutide shines in phase III trial
Survodutide could become first global glucagon/GLP-1 dual agonist, new phase III findings suggest.
-
NewsManufacturing data innovation set to accelerate medicine development
CMAC’s milestone aids the pharmaceutical industry’s transition from manual and siloed data operations to connected, intelligent manufacturing systems.
-
NewsUpcycled plastic could facilitate production of Parkinson’s drug
Bioengineered E.coli provide an eco alternative to creating L-DOPA from terephthalic acid, suggests study.
-
NewsSana's islet cell transplant therapy shows early promise in type 1 diabetes
Biotech company’s long-term data demonstrated hypoimmune (HIP)-modified islet transplantation without immunosuppression in type 1 diabetes.
-
NewsStudy optimises automated de-bagging in aseptic manufacturing
Mechanical design improvements greatly enhanced success rate during primary de-bagging for double-bag products.
-
NewsFDA revises PK study approach in new biosimilar draft guidance
Sandoz is also adjusting its global strategy by recruiting Armin Metzger as President of Biosimilar Development, Manufacturing & Supply.
-
NewsCleanroom air quality not impaired by height-adjustable furniture
Incorporating ergonomic improvements into pharmaceutical cleanrooms may not negatively impact particle contamination control, according to a new study.
-
NewsNanofiltration study highlights next-generation water treatment process
The technology could offer defect-free, high-efficiency ceramic-based water filtration through ultra-precise control of nanopores and surface structure.
-
NewsBiogen/Stoke’s zorevunersen hailed as potential first disease-modifying drug for rare epilepsy
Clinical readout for Dravet syndrome trial part of the collaboration the companies signed in 2025.